12:38 PM EST - Labopharm Inc. : announced its twice-daily tramadol-acetaminophen has received a positive opinion under the European Union Decentralized Procedure in eight countries (Czech Republic, Iceland, Ireland, Poland, Portugal, Slovakia, Slovenia and Spain). Marketing Authorization will be granted in each country subject to the approval of translations of the Summary of Product Characteristics and other labeling documents. Labopharm Inc.
shares T.DDS are trading up $.09 at $1.06.
